insights_auto
Why is INO up 4,34%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
0,93 $
arrow_upward
+4,34%(+0,039) 1D
0,94 $
arrow_upward
+1,23% (+0,011)bedtimeAfter hours
Closed: 28 қаз., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
0,93 $
High
0,98 $
Low
0,91 $
Mkt. cap
96,01 млн
Avg. vol.
3,59 млн
Volume
4,49 млн
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-1,17 $
Beta
1,61
Shares outstanding
103,40 млн
No. of employees
112
Open
0,93 $
High
0,98 $
Low
0,91 $
Mkt. cap
96,01 млн
Avg. vol.
3,59 млн
Volume
4,49 млн
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-1,17 $
Beta
1,61
Shares outstanding
103,40 млн
No. of employees
112
News stories
From web sources and news partners
The Business Journals
·
1 сағат бұрын
After $80M court judgment, Inovio could get even better news from the FDA
www.marketscreener.com
·
19 сағат бұрын
Certain Stock Options of Inovio Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 28-OCT-2026.
News Corp
·
23 сағат бұрын
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc